REPL

Replimune Group, Inc. REPL

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-69.77M

Quarter to Jun 30

Free cash flow

$-75.73M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$1.06B total
Reading the latest SEC filing…

Key Metrics

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Debt/Equity

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/REPL

Earnings Per Share

13fpro.ai/company/REPL

Loading ratio trend…

About Replimune Group, Inc. (REPL): stock profile, AI score and financials

Replimune Group, Inc. (REPL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. REPL is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2027), Replimune Group, Inc. reports net income of $-69.8M, free cash flow of $-75.7M. REPL trades on the Nasdaq exchange and files with the SEC under CIK 1737953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate REPL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Replimune Group, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1737953 →